Abstract
ABSTRACTHPMCAS/theophylline composite nanofibers, which displayed a significant pH‐responsive behavior, were successfully fabricated through electrospinning. SEM observations demonstrated that the nanofibers were linear with a smooth and unordered structure. Mean diameter of the composite nanofibers increased with the content of drug. FT‐IR spectra confirmed that theophylline was successfully loading into HPMCAS nanofibers. XRD, DSC, and TGA verified that theophylline blended with HPMCAS in a physical level and had retained its crystalline state in the composite nanofibers, which further demonstrated that the drug efficacy did not destroy in the electrospinning process. Drug loading testing showed that drug loading percent and encapsulation efficiency increased with the content of drug, except the 4% drug content sample, which was confirmed to be decided by the beaded morphology. Furthermore, the in vitro drug release studies revealed that the composite nanofibers particularly showed rapid theophylline release at weak alkaline pH environment and exhibited a burst release in the first hour followed by a decreased tendency. However, the release ratio was still at a high level after 12 h. The release process can be helpful to the urgent sudden disease, meanwhile to reduce the suffering of patients and the required frequency of drug administration. © 2019 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2020, 137, 48383.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.